jojoarcadegame| Tianyan Pharmaceutical's intraday movements rose rapidly by 5.02% to US$2.72

Beijing time at 23:05 on May 22, 2024jojoarcadegame, Tianyan Pharmaceutical (ADAGjojoarcadegame.us) Stocks changed, and the stock price rose rapidly by 5%jojoarcadegame.02%。As of press time, the stock was trading at US$2.72/share, with a trading volume of 3031 shares, a turnover rate of 0.01%, and an amplitude of 1.58%.

recentjojoarcadegameFinancial report data showed that the stock achieved operating income of US$18.11 million, net profit of US$18.95 million, earnings per share of US$0.43, gross profit--, and a P/E ratio of-5.94 times.

In terms of institutional ratings, among all two institutions participating in the rating, 100% of securities firms gave buy suggestions, and no securities firm gave hold or sell suggestions.

In the biotechnology industry where Tianyan Pharmaceutical shares are located, the overall increase was 0.36%. Among its related stocks, Igm Biosciences, Inc., Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 (To Pur Com), Humacyte Inc C/Wts 27/08/2026 (To Pur Com) increased significantly, Mustang Bio, Inc., Biodexa Pharmaceuticals Plc and Coeptis Therapeutics Holdings, Inc. are relatively active, with turnover rates of 286.02%, 144.78%, and 38.93%, respectively. Related stocks with larger amplitudes include Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 (To Pur Com), Alpha Tau Medical Ltd C/Wts (To Pur Com), and Oragenics Inc. The amplitudes were 57.14%, 48.75%, and 47.70%, respectively.

Introduction to Tianyan Pharmaceutical Company: Tianyan Pharmaceutical Co., Ltd. is a platform-driven clinical biopharmaceutical company engaged in the transformation of discovery and development of new antibody-based cancer immunotherapies. It is mainly engaged in the research and development and production of cancer monoclonal antibody drugs. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and multi-species cross-reactivity, which is highlighted in the company's immunotherapy products.

(The above content is Tencent's self-selected shares based on public information and intelligently generated by programs or algorithms. It is only used as a reference for users to watch the market, and is not used as investment advice or trading basis. The stock market is risky, please make decisions carefully.)

Tags:

Prev: freeslotswithbonusandfreespinswheeloffortune| Guangdong Province: Accelerate the reform of low-altitude airspace management and strive for pilot demonstrations of low-altitude economies
Next: candycrushsodasagaking| Yida Shares: The rise in the price of ethylene glycol butyl ether products has promoted the company's operating performance